首页> 外国专利> N-TERMINAL PEPTIDES OF SDF-1 HAVE FUNCTIONAL ACTIVITIES MEDIATED BY CXCR4

N-TERMINAL PEPTIDES OF SDF-1 HAVE FUNCTIONAL ACTIVITIES MEDIATED BY CXCR4

机译:SDF-1的N末端肽具有CXCR4介导的功能活性

摘要

Peptides correspond ing to the N-terminal 9 residues of stromal cell derivedfactor-1 (SDF-1) have SDF-1activity. Peptides, corresponding to residues 1-8, 1-9, and a disulfide linkeddimer of 1-9, involvingCys-9, induced chemotaxis in T lymphocytes and CEM cells, and bound the SDF-1receptor, CXCchemokine receptor 4 (CXCR4). The peptides had similar activities to SDF-1,but were less potent.Whereas native SDF-I had half maximal chemoattractant activity at 5 nM, the 1-9 direr and a 1-9monomer analog were 100- and 3600-fold less potent, respectively. Receptordesensitization andcompetition binding experiments indicated that the SDF-1 peptides are specificfor CXCR4. As Cys-9 isinvolved in a disulfide bridge with Cys 34 in native SDF-1, it is possiblethat the disulfide of the peptidedimer enhances its structural similarity to the native protein. Overall thisstudy shows that the N-terminalregion is sufficient to bind and activate CXCR4, which suggests thefeasibility of designing smallCXCR4 agonists or antagonists.
机译:相应于基质细胞衍生的N端9个残基的肽因子1(SDF-1)具有SDF-1活动。对应于残基1-8、1-9和二硫键的肽1-9的二聚体,涉及Cys-9,诱导T淋巴细胞和CEM细胞趋化性并结合SDF-1受体,CXC趋化因子受体4(CXCR4)。这些肽具有与SDF-1类似的活性,但效力较弱。而天然SDF-1在5 nM时具有最大的一半化学趋化活性,而1-9 direr和1-9单体类似物的效力分别降低了100倍和3600倍。受体脱敏和竞争结合实验表明SDF-1肽具有特异性用于CXCR4。因为Cys-9是与天然SDF-1中的Cys 34参与二硫键时,可能肽的二硫键二聚体增强了其与天然蛋白质的结构相似性。总体来说研究表明N端该区域足以结合并激活CXCR4,这表明设计小型的可行性CXCR4激动剂或拮抗剂。

著录项

  • 公开/公告号CA2226391A1

    专利类型

  • 公开/公告日1999-09-13

    原文格式PDF

  • 申请/专利权人 THE UNIVERSITY OF BRITISH COLUMBIA;

    申请/专利号CA19982226391

  • 发明设计人 UNKNOWN;

    申请日1998-03-13

  • 分类号C07K14/52;A61K38/08;A61K38/19;C07K7/06;C12Q1/02;G01N33/566;

  • 国家 CA

  • 入库时间 2022-08-22 02:24:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号